Although he is presently focused on drugs targeting obesity and cancer, his next objective is the development of pharmaceuticals for cardiovascular diseases that primarily affect male patients.
ARLINGTON, MA, February 21, 2024 /24-7PressRelease/ — Arfaxad Reyes Alcaraz, PhD, has been included in Marquis Who’s Who. As in all Marquis Who’s Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Leveraging more than a decade of excellence in drug development for cancer, cardiovascular diseases, obesity and other diseases, Dr. Reyes Alcaraz has earned distinction as a senior scientist with Amgen Inc. Since 2023, he has focused his efforts on conducting experiments critical for the introduction of new drugs spanning diverse therapeutic domains. He also works on the regulatory filings for these drugs, particularly for the FDA and equivalent agencies internationally. Having personally experienced numerous illnesses during his formative years, he is committed to providing good health and quality of life for patients.
Before his present role, Dr. Reyes Alcaraz worked as a postdoctoral researcher for Korea University for five years and for the University of Houston from 2019 until 2023. He also served as a volunteer judge at a science foundation, assessing projects related to science, climate change and electronics presented by high schoolers and early beginners at the University of Houston. To prepare for his professional journey, he earned a Doctor of Philosophy from the Polytechnic University of Catalonia in Barcelona, Spain in 2011.
Among his professional accomplishments, Dr. Reyes Alcaraz was recognized by the University of Houston for exemplary scientific research. He also successfully completed undergraduate and postgraduate studies through scholarships, including awards from the Mexican government and the Brain Korea 21 program at Korea University dedicated to nurturing exceptional scholars who play a pivotal role in addressing societal shifts.
Within the coming years, Dr. Reyes Alcaraz intends to continue his work across a broader spectrum of therapeutic areas. Although he is presently focused on drugs targeting obesity and cancer, his next objective is the development of pharmaceuticals for cardiovascular diseases that primarily affect male patients. Thus far, he is proud to have been involved in innovating technologies that have been integrated into the pharmaceutical industry, with his contributions extending to drugs treating cardio-pulmonary diseases and various brain disorders, including schizophrenia, bipolar disorder and anxiety.
About Marquis Who’s Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who’s Who in America®, Marquis Who’s Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Marquis celebrates its 125th anniversary in 2023, and Who’s Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® publications may be visited at the official Marquis Who’s Who® website at www.marquiswhoswho.com.
# # #
